Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Mesenchymal stem cells (MSCs) loaded with oncolytic viruses are presently being investigated as a new modality of advanced/metastatic tumors treatment and enhancement of virotherapy. MSCs can, however, either promote or suppress tumor growth. To address the critical question of how MSCs loaded with...
Main Authors: | Mahasa, K, De Pillis, L, Ouifki, R, Eladdadi, A, Maini, P, Yoon, A, Yun, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2020
|
Similar Items
-
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.
by: Khaphetsi Joseph Mahasa, et al.
Published: (2017-01-01) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01) -
Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01) -
Oncolytic Virotherapy: The Cancer Cell Side
by: Marcelo Ehrlich, et al.
Published: (2021-02-01) -
Editorial: Oncolytic virotherapy
by: Ahmed Majeed Al-Shammari, et al.
Published: (2023-11-01)